Literature DB >> 21661677

Use of intranasal medications in pediatric patients.

Susan E Warrington1, Robert J Kuhn.   

Abstract

A growing body of evidence supports the intranasal administration of atomized medications for a wide variety of pediatric indications. This article describes their use applicable to orthopedic specialists in the areas of pediatric pain management, as well as pre- and intraoperative sedation. As a quick, painless alternative to more invasive routes of administration, intranasal drug delivery has shown similar time to clinical effect compared to the intravenous route, while minimizing anxiety in both patients and their parents. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21661677     DOI: 10.3928/01477447-20110427-20

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

1.  Comparison between intranasal dexmedetomidine and intranasal ketamine as premedication for procedural sedation in children undergoing MRI: a double-blind, randomized, placebo-controlled trial.

Authors:  Prakhar Gyanesh; Rudrashish Haldar; Divya Srivastava; Prashant Mohan Agrawal; Akhilesh Kumar Tiwari; P K Singh
Journal:  J Anesth       Date:  2013-06-26       Impact factor: 2.078

2.  A cohort study of intranasal fentanyl for procedural pain management in neonates.

Authors:  Carol McNair; Brenda Graydon; Anna Taddio
Journal:  Paediatr Child Health       Date:  2018-05-24       Impact factor: 2.253

3.  Effect of Intranasal Sedation Using Ketamine and Midazolam on Behavior of 3-6 Year-Old Uncooperative Children in Dental Office: A Clinical Trial.

Authors:  Majid Mehran; Sara Tavassoli-Hojjati; Nazila Ameli; Mehdi Salehi Zeinabadi
Journal:  J Dent (Tehran)       Date:  2017-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.